The Latest
-
Novo, Hims reach deal to sell GLP-1 drugs together
The agreement ends a messy dispute that began when the telehealth firm attempted to sell a compounded form of Novo’s Wegovy pill at a cheaper price.
-
UHS to acquire Talkspace for $835M as hospital operator pursues behavioral health growth
Shortages of behavioral healthcare providers have been a bottleneck to UHS’ growth. Monday’s acquisition of Talkspace for $5.25 a share should help the for-profit hospital giant get around that.
-
Agilent to buy Biocare Medical for $950M
Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.
-
The image by Brandonrush is licensed under CC BY-SA 3.0
CHS to offload 4 hospitals in Arkansas
It's yet another divestiture for CHS, which has embarked on a sales spree as the operator looks to pay down debt.
-
HHS gets serious on information blocking enforcement
Nearly a decade after Congress banned information blocking, the HHS is making progress cracking down on health IT developers accused of the practice, an agency head said during a Senate subcommittee hearing.
-
Retrieved from FDA.
Vinay Prasad, controversial FDA leader, to again depart agency
Prasad’s planned departure, expected at the end of April, culminates a tumultuous term in which he reworked vaccine guidelines and was criticized for his office’s stance on several rare disease drugs.
Updated March 7, 2026 -
HHS adds cybersecurity guidance to healthcare sector self-assessment tool
Organizations can now use the online platform to test their readiness for digital security crises.
-
Mayo Clinic rides admissions gains to higher net revenue in 2025
The Rochester, Minnesota-based nonprofit health system said increases in outpatient, hospital and surgical volumes boosted revenue for the year.
-
Hospitals urge regulators to halt drugmakers’ expanded 340B data policies
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
-
Amazon launches suite of healthcare AI agents
Amazon Connect Health can help patients schedule appointments as well as assist providers by creating summaries of patients’ medical histories, documenting care and generating diagnosis and billing codes.
-
Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC
It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.
-
CVS, Google Cloud partner on healthcare consumer engagement platform
Health100, set to launch this year, will collect patients’ data from across the healthcare ecosystem, help them find care and use AI to provide education and guidance, CVS said.
-
CMS receives record comments on controversial Medicare Advantage payment proposal
The Trump administration wants to keep MA rates flat next year and change how risk adjustment is calculated. Insurers had a lot to say about this, CMS officials shared Tuesday during an event in D.C.
-
CMS innovation center remains focused on mandatory models, officials say
CMMI Director Abe Sutton and CMS Administrator Dr. Mehmet Oz outlined how the administration aims to get more providers, especially poor-performing ones, into value-based models at a D.C. event on Tuesday.
-
State Medicaid budgets face $664B cut due to ‘Big Beautiful Bill’: study
Twenty states are projected to experience Medicaid budget reductions of 5% or more from the law’s cuts to the safety-net insurance program, according to the Rand analysis.
-
Brian Evanko to succeed David Cordani as CEO of Cigna
Evanko, currently the insurer’s COO, will assume the chief executive role after Cordani retires in July.
-
Education Department urged to broaden ‘professional’ student definition
Professional students will be able to borrow $100,000 more than other graduate students, but a proposed rule would exclude certain healthcare fields, like advanced nursing and physician associates, from the higher cap.
-
CMS threatens Elevance with Medicare Advantage sanctions
Federal regulators are planning to suspend enrollment in Elevance's MA plans at the end of March, in a rare and serious threat to the company’s finances.
-
Trump administration targets DME suppliers in fraud crackdown
The government plans a six-month moratorium on supplier enrollment in the Medicare program to find ways to stop what it called “longstanding instances of fraud, waste, and abuse” by certain companies.
-
Provider groups push to preserve some IT certification criteria, including AI ‘model cards’
A proposed rule would cull or revise dozens of health IT certification criteria, but providers say regulators should keep some of them to avoid shifting costs or compliance responsibilities back onto clinicians.
-
AMA creates new maternity care coding system
The doctors’ association is blowing up the U.S.’ decades-old coding system for recording pregnancy services and starting fresh next year, bowing to calls from OB-GYNs and other maternity specialists.
-
University of Mississippi Medical Center reopens clinics after ransomware attack
The academic medical center’s clinics can once again access patient records and are resuming normal operations more than a week after the attack.
Updated March 2, 2026 -
Former Optum chief departs UnitedHealth
Heather Cianfrocco, an executive vice president at UnitedHealth and former CEO of its health services division Optum, announced she was leaving the company after a 24-year tenure.
-
Elevance shuffles C-suite as top Carelon exec departs
The leadership changes at Elevance’s main growth engine Carelon — and the company’s decision to centralize oversight of its health plans — come as Elevance looks to bolster waning profits.
-
How PBM reforms could push drugmakers into the pricing spotlight
The Consolidated Appropriations Act’s landmark PBM overhaul removes financial incentives tied to pharma list prices, potentially leaving drugmakers to defend their own practices.